Abivax nears $11 billion valuation after fundraising eases M&A pressure - Reuters
Abivax nears $11 billion valuation after fundraising eases M&A pressure Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPNlNyUXYxZE85cFdYaVdKSldIbHR1QVVxT2ZhOTUzcmo2c3dZSXZ6c2hGSWlYSXpUQzE0T0xIbU1vTjhyRVd4YW4xdmlNdVc0My1hWWNxR29vc0hMY3pLOUt6RzczSFc2T25IbTIyVklKR09zbGw0Q3NZeXVkSUhRUG9LcHdSSkZKYnhoUXlXR0hRc04wd2tUeXpDYXNScmZuQXRoV0p4WHhlTFVQZjEzUGF1Tm5PVFFfMWJVbk0wSQ?oc=5" target="_blank">Abivax nears $11 billion valuation after fundraising eases M&A pressure</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMGerman robot startup RobCo hits $1 billion valuation, CEO moves to US - Reuters
German robot startup RobCo hits $1 billion valuation, CEO moves to US Reuters
October 5, 2026 at 05:25 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMDental firm vVardis reveals revenue surge in US IPO filing - Reuters
Dental firm vVardis reveals revenue surge in US IPO filing Reuters
October 9, 2026 at 07:31 PM